Çalı, A. Et Al. 2023. FDA-Approved Molecular Tests Used to Define Human Papillomavirus (HPV) Infections which Cause Cervix Cancer. Cumhuriyet Medical Journal , vol.45, no.1 , 1-11.

Çalı, A., Aslan, R., Çelik, C., & Alim, A., (2023). FDA-Approved Molecular Tests Used to Define Human Papillomavirus (HPV) Infections which Cause Cervix Cancer. Cumhuriyet Medical Journal , vol.45, no.1, 1-11.

Çalı, ABDULHAMİT Et Al. "FDA-Approved Molecular Tests Used to Define Human Papillomavirus (HPV) Infections which Cause Cervix Cancer," Cumhuriyet Medical Journal , vol.45, no.1, 1-11, 2023

Çalı, ABDULHAMİT Et Al. "FDA-Approved Molecular Tests Used to Define Human Papillomavirus (HPV) Infections which Cause Cervix Cancer." Cumhuriyet Medical Journal , vol.45, no.1, pp.1-11, 2023

Çalı, A. Et Al. (2023) . "FDA-Approved Molecular Tests Used to Define Human Papillomavirus (HPV) Infections which Cause Cervix Cancer." Cumhuriyet Medical Journal , vol.45, no.1, pp.1-11.

@article{article, author={ABDULHAMİT ÇALI Et Al. }, title={FDA-Approved Molecular Tests Used to Define Human Papillomavirus (HPV) Infections which Cause Cervix Cancer}, journal={Cumhuriyet Medical Journal}, year=2023, pages={1-11} }